Effect of Accurate Mass MS Data Acquisition Rate on Data Quality in Metabolic Phenotyping Studies
Technical notes | 2017 | WatersInstrumentation
Accurate mass spectrometry (MS) data acquisition rate is critical in metabolic phenotyping to balance chromatographic resolution, mass resolution, and throughput. As large-scale studies involve hundreds to thousands of biological samples, maintaining data quality while ensuring rapid analysis is essential for reliable biomarker discovery and quantification.
This study evaluates how MS acquisition speed influences LC-MS data quality in metabolic phenotyping of biological fluids. Emphasis is placed on the trade-off between scan time, mass resolution, and chromatographic detail when using high-resolution MS instruments.
Samples: Human urine diluted and analyzed in positive-ion mode.
• Chromatographic resolution declines as scan time increases above 0.05 s, with a plateau until 0.5 s and further loss beyond 1.0 s, causing peak merging and loss of fine detail.
• For peaks 1-3 s wide at the base, 8-10 data points require 50-100 ms scan rates to ensure accurate quantification.
• Time-of-flight MS maintains resolution independently of scan speed, whereas Fourier-transform MS (FTMS) instruments lose mass resolution when acquisition time decreases.
Combining UPLC and fast TOF-MS enables high-throughput metabolic phenotyping without compromising chromatographic or mass spectral quality. This approach supports robust quantification, minimizes missed analytes, and is suited to large cohort studies in metabolomics, metabonomics, and clinical biomarker research.
Advances in detector technology and scan electronics may push acquisition speeds higher while preserving resolution. Integration with machine learning could further enhance peak deconvolution and feature extraction. Expanding to multi-omics platforms and real-time data analysis will drive more comprehensive metabolic profiling.
Optimizing MS acquisition rates is vital for balancing speed and data fidelity in metabolic phenotyping. Fast TOF instruments paired with UPLC deliver the resolution and throughput needed for large-scale studies, ensuring rich, reliable data for biomarker discovery.
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesMetabolomics, Clinical Research
ManufacturerWaters
Summary
Importance of the Topic
Accurate mass spectrometry (MS) data acquisition rate is critical in metabolic phenotyping to balance chromatographic resolution, mass resolution, and throughput. As large-scale studies involve hundreds to thousands of biological samples, maintaining data quality while ensuring rapid analysis is essential for reliable biomarker discovery and quantification.
Study Objectives and Overview
This study evaluates how MS acquisition speed influences LC-MS data quality in metabolic phenotyping of biological fluids. Emphasis is placed on the trade-off between scan time, mass resolution, and chromatographic detail when using high-resolution MS instruments.
Methodology and Used Instrumentation
Samples: Human urine diluted and analyzed in positive-ion mode.
- LC system: UPLC with 2.1 x 150 mm HSS T3 column, sub-2 um particle size, 40 C, flow rate 600 uL/min.
- Gradient: 0-55% aqueous to acetonitrile over 10-15 min.
- MS: Xevo G2-XS QTof with QuanTof detector.
- Scan rates tested: 0.0036 s to 1.0 s per spectrum.
Main Results and Discussion
• Chromatographic resolution declines as scan time increases above 0.05 s, with a plateau until 0.5 s and further loss beyond 1.0 s, causing peak merging and loss of fine detail.
• For peaks 1-3 s wide at the base, 8-10 data points require 50-100 ms scan rates to ensure accurate quantification.
• Time-of-flight MS maintains resolution independently of scan speed, whereas Fourier-transform MS (FTMS) instruments lose mass resolution when acquisition time decreases.
Benefits and Practical Applications
Combining UPLC and fast TOF-MS enables high-throughput metabolic phenotyping without compromising chromatographic or mass spectral quality. This approach supports robust quantification, minimizes missed analytes, and is suited to large cohort studies in metabolomics, metabonomics, and clinical biomarker research.
Future Trends and Opportunities
Advances in detector technology and scan electronics may push acquisition speeds higher while preserving resolution. Integration with machine learning could further enhance peak deconvolution and feature extraction. Expanding to multi-omics platforms and real-time data analysis will drive more comprehensive metabolic profiling.
Conclusion
Optimizing MS acquisition rates is vital for balancing speed and data fidelity in metabolic phenotyping. Fast TOF instruments paired with UPLC deliver the resolution and throughput needed for large-scale studies, ensuring rich, reliable data for biomarker discovery.
References
- Wong RL, Xin B, Olah T. Optimization of Exactive Orbitrap acquisition parameters for quantitative bioanalysis. Bioanalysis. 2011;3(8):863-71.
- Gika HG, Theodoridis GA, Plumb RS, Wilson ID. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal. 2014;87:12-25.
- Plumb RS, Rainville P, Smith BW, Johnson KA, Castro-Perez J, Wilson ID, Nicholson JK. Generation of ultrahigh peak capacity LC separations via elevated temperatures and high linear mobile-phase velocities. Anal Chem. 2006;78(20):7278-83.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Stability of the ACQUITY UPLC System with Xevo G2-XS QTof Mass Spectrometer for Metabolic Phenotyping of Human Urine in Large Cohort Studies
2016|Waters|Applications
[ TECHNOLOGY BRIEF ] Stability of the ACQUITY UPLC System with Xevo G2-XS QTof Mass Spectrometer for Metabolic Phenotyping of Human Urine in Large Cohort Studies The combination of the ACQUITY UPLC System and Xevo G2-XS QTof Mass Spectrometer demonstrates…
Key words
metabolic, metabolicvariation, variationuplc, uplcacquity, acquitycohort, cohortstudies, studiesreproducibility, reproducibilitywaters, watersbrief, briefmanifests, manifestsemployed, employedanalysis, analysisepidemiological, epidemiologicalprofiling, profilingskewing
Evaluation of Ion Mobility/Tof Mass Spectrometry with Multiple LC Method Parameters for Enhanced Detection in Metabolic Profiling
2017|Waters|Applications
[ APPLICATION NOTE ] Evaluation of Ion Mobility/Tof Mass Spectrometry with Multiple LC Method Parameters for Enhanced Detection in Metabolic Profiling Paul D. Rainville,1 Ian D. Wilson, 2 and Robert S. Plumb 1,2 1 Waters Corporation, Milford, MA, USA 2…
Key words
mobility, mobilityims, imsfeatures, featuresdetection, detectiongradient, gradientdetected, detectedduration, durationion, ionfeature, featuretof, tofuplc, uplcspectrometry, spectrometryenhanced, enhancedmetabonomics, metabonomicsevaluation
Tips and tricks for LC–MS-based metabolomics and lipidomics analysis
2024|Agilent Technologies|Scientific articles
Trends in Analytical Chemistry 180 (2024) 117940 Contents lists available at ScienceDirect Trends in Analytical Chemistry journal homepage: www.elsevier.com/locate/trac Tips and tricks for LC–MS-based metabolomics and lipidomics analysis Stanislava Rakusanova , Tomas Cajka * Institute of Physiology of the Czech…
Key words
metabolomics, metabolomicslipidomics, lipidomicsuntargeted, untargetedmetabolites, metabolitesdata, databased, basedextraction, extractionshould, shouldnormalization, normalizationduring, duringlipids, lipidsmethods, methodsmass, massmetabolome, metabolomeusing
Rapid Microbore Metabolic Profiling (RAMMP) with Ion Mobility for the Lipidomic Investigation of Plasma from Breast Cancer Patients
2018|Waters|Applications
[ APPLICATION NOTE ] Rapid Microbore Metabolic Profiling (RAMMP) with Ion Mobility for the Lipidomic Investigation of Plasma from Breast Cancer Patients Adam M. King,1 Lee A. Gethings,1 and Robert S. Plumb 2 1 Waters Corporation, Wilmslow, UK; 2 Waters…
Key words
rammp, rammplipidomic, lipidomicmicrobore, microboremetabolic, metabolicprofiling, profilinglipid, lipidbreast, breastmobility, mobilityinvestigation, investigationpatients, patientscancer, cancerrapid, rapidplasma, plasmauplc, uplcprogenesis